Denali Capital Acquisition Corp. held an extraordinary general meeting of shareholders on September 3, 2025. At the meeting, several proposals were presented and approved by the shareholders. The Agreement and Plan of Merger, involving Denali, Denali Merger Sub Inc., and Semnur Pharmaceuticals, Inc., was approved. The shareholders also approved Denali's continuation and domestication into the State of Delaware, including the Amended and Restated Certificate of Incorporation and Bylaws of Semnur Pharmaceuticals, Inc. Additionally, the proposed amended and restated certificate of incorporation and bylaws of the company were approved to be effective upon the domestication.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Denali Capital Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-084180), on September 04, 2025, and is solely responsible for the information contained therein.